← back to database

Red Tree Venture Capital

HQ · California
WebsiteLinkedInUpdate entry

Red Tree Venture Capital is an early-stage-biased life-sciences firm investing in first- and best-in-class therapeutics. Its West Coast-centric strategy leverages relationships with leading academic and research institutions and concentrates on areas including oncology, neurology, and immunology.

Stage focus
SeedSeries A
Lead / follow
Mostly Lead
Ownership target
7-10%
Specialization
Life Sciences
Generalist / Specialist

Specialist

Latest fund size

Red Tree Venture Fund II

Latest fund vintage

2025

Investing team
  • Heath LukatchCo-Founder and Managing Partner
  • Jeremy CaldwellManaging Director
Notable investments

Bicara Therapeutics, Ceribell, Cargo Therapeutics, Contineum Therapeutics

Sources
redtreevc.com ↗redtreevc.com/our-approach ↗redtreevc.com/team ↗redtreevc.com/portfolio ↗sec.gov/Archives/edgar/data/1973897/000197389725000001/0001973897-25-000001-index.htm ↗

Spotted an error on this profile?

Similar firms

DimensionPre-Seed / Inception · Seed · $3M - $10Mview profile →Good Growth CapitalPre-Seed / Inception · Seed · $250-500kview profile →Seae VenturesSeed · Series A · $1-3mview profile →
Red Tree Venture Capital — early-stage investor profile | findfunding.vc